Immuno Oncology Talks
Adoptive therapy with engineered T cell receptors
25 tammikuun, 2023
00:29:32
Speaker(s)
Reno Debets
In the current, and fifth episode of the “Immuno Oncology Talks”, we discuss adoptive therapy with engineered T cell receptors, with Professor Reno Debets from the Erasmus MC Cancer Institute in the Netherlands. Professor Debets research aims to explore therapeutic strategies by developing and testing adoptive T cell therapy and understand and intervene with the cross-talk between tumor cells and T cells.
For more information please visit:
Sanofi Immuno Oncology Talks website
MAT-BE-2300064 (Ver 1.0) Jan 2023
Also interesting...
MGUS, Science
Risk stratification in patients with monoclonal Gammopathies
Hematology
Sickle cell disease – A hereditary blood disorder
Hematology
Cancer cell and gene therapies and the challenges to access the market
Hematology, Hematology, Waldenström
Waldenström Macroglobulinemia: a clinical update
Hematology, Hematology